At the same time, the drug development horizon is full of promising directions: oral formulations, multi-agonists, longer-acting molecules, and the emergence of biomarkers to personalize therapy
Confirm whether the medication is compounded or FDA-approved
GLP-1 (glucagon-like peptide-1) receptor agonists - such as semaglutide - work by mimicking a naturally occurring hormone that helps regulate appetite, slows stomach emptying, and signals the brain to reduce hunger
Waiting ensures: More predictable, longer-lasting results Reduced risk of needing revision surgery due to ongoing weight changes Most patients are advised to maintain a stable weight for several months before proceeding with body contouring, facial surgery, or breast procedures
As doses increase, monthly weight loss typically ranges from 4-8 pounds during peak loss phases